Completed PHASE3 INTERVENTIONAL NCT00124774

Nucleoplasty for Contained Herniated Lumbar Discs

Nucleoplasty for Contained Herniated Lumbar Discs: A Randomised, Double Blind, Prospective Comparison With Sham Treatment

Sponsor: ArthroCare Corporation

Conditions Herniated Disc

Interventions Nucleoplasty

Updated 6 times since 2017 Last updated: Mar 28, 2008 Started: Nov 30, 2004 Completion: Apr 30, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Herniated Disc, this trial is completed. The trial is conducted by ArthroCare Corporation and has accumulated 6 data snapshots since 2004. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE3
Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Nov 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

ArthroCare Corporation
Maastricht University
Rijnstate Hospital

Data source: Rijnstate Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Arnhem, Netherlands